Riqiclav-625 Tablets

Riqiclav-625 Tablets is a combination of Amoxycillin 500 mg and Potassium Clavulanate 125 mg, formulated for the treatment of a broad range of susceptible bacterial infections. Amoxycillin provides effective antibacterial action, while Clavulanic Acid enhances its activity by inhibiting beta-lactamase enzymes produced by resistant bacteria. It is commonly prescribed for respiratory tract, ear, nose and throat, urinary tract, skin, soft tissue, and dental infections. The film-coated tablet offers convenient oral administration and should be used only under the guidance of a qualified healthcare professional.

Category:

Description

Amoxycillin & Potassium Clavulanate Tablets I.P.

Riqiclav-625 Tablets is a broad-spectrum antibiotic combination containing Amoxycillin and Potassium Clavulanate, formulated for the treatment of a wide range of susceptible bacterial infections. Amoxycillin is a penicillin-class antibiotic that works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from degradation by bacterial enzymes, thereby extending its antibacterial spectrum against resistant organisms.

The combination is commonly prescribed for infections of the respiratory tract, ear, nose and throat, urinary tract, skin and soft tissues, dental infections, and other susceptible bacterial infections. Riqiclav-625 Tablets provide reliable antibacterial coverage and should be used only under the supervision of a qualified healthcare professional. Completing the full prescribed course helps ensure effective treatment and reduces the risk of antibiotic resistance.

Key Benefits

  • Broad-spectrum antibacterial activity.
  • Effective against beta-lactamase-producing bacteria.
  • Helps treat a wide range of susceptible bacterial infections.
  • Provides enhanced antibacterial coverage through dual-action formulation.
  • Supports effective infection management in respiratory, urinary, skin, and dental infections.
  • Film-coated tablets for convenient oral administration.
  • Intended for use under medical supervision.

Composition

Each film-coated tablet contains:

  • Amoxycillin Trihydrate IP equivalent to Amoxycillin 500 mg
  • Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 125 mg

Indications

Recommended for the treatment of susceptible bacterial infections, including:

  • Upper and lower respiratory tract infections
  • Ear, nose, and throat infections
  • Sinusitis
  • Urinary tract infections
  • Skin and soft tissue infections
  • Dental infections
  • Bone and joint infections, as advised by the physician

Directions for Use

Take the tablet exactly as prescribed by the physician, preferably at the start of a meal to improve absorption and reduce stomach discomfort. Swallow the tablet whole with water and complete the full course of treatment, even if symptoms improve earlier.

Storage

  • Store below 25°C in a cool and dry place.
  • Protect from moisture and direct sunlight.
  • Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “Riqiclav-625 Tablets”

Your email address will not be published. Required fields are marked *